Virtual Screening and Design with Machine Intelligence Applied to Pim‐1 Kinase Inhibitors
Open Access
- 17 June 2020
- journal article
- research article
- Published by Wiley in Molecular Informatics
- Vol. 39 (9) , e2000109
Abstract
Ligand‐based virtual screening of large compound collections, combined with fast bioactivity determination, facilitate the discovery of bioactive molecules with desired properties. Here, chemical similarity based machine learning and label‐free differential scanning fluorimetry were used to rapidly identify new ligands of the anticancer target Pim‐1 kinase. The three‐dimensional crystal structure complex of human Pim‐1 with ligand bound revealed an ATP‐competitive binding mode. Generative de novo design with a recurrent neural network additionally suggested innovative molecular scaffolds. Results corroborate the validity of the chemical similarity principle for rapid ligand prototyping, suggesting the complementarity of similarity‐based and generative computational approaches.Keywords
This publication has 41 references indexed in Scilit:
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitorsBioorganic & Medicinal Chemistry Letters, 2011
- Data processing and analysis with theautoPROCtoolboxActa Crystallographica Section D Structural Biology, 2011
- REFMAC5 for the refinement of macromolecular crystal structuresActa Crystallographica Section D Structural Biology, 2011
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- The Protein Data BankNucleic Acids Research, 2000
- Long Short-Term MemoryNeural Computation, 1997
- The Properties of Known Drugs. 1. Molecular FrameworksJournal of Medicinal Chemistry, 1996
- Self-organized formation of topologically correct feature mapsBiological Cybernetics, 1982